REGISTERED
on 26 Nov 2024
Last Applicant/ Owned by
NL-5349 AB Oss
NL
Serial Number
79358195 filed on 26th Apr 2023
Registration Number
7574608 registered on 26th Nov 2024
Correspondent Address
E. Anthony Figg
E. Anthony Figg Rothwell, Figg, Ernst & Manbeck, PC
Suite 900 East
Washington, DC 20001
United States
Filing Basis
1. filing basis filed as 66 a
Disclaimer
NO DATA
BIOCONNECTION
Product research and development; research and development in the pharmaceutical and biotechnology field; research and development of new products for others; development of pharmaceutical preparations and medicines; services of bio technical, chemical and pharmaceutical laboratories, including scientific and technological research relating to the production of chemicals and biotechnological produ Read More
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Product research and development; research and development in the pharmaceutical and biotechnology field; research and development of new products for others; development of pharmaceutical preparations and medicines; services of bio technical, chemical and pharmaceutical laboratories, including scientific and technological research relating to the production of chemicals and biotechnological products for use in preparing pharmaceutical and veterinary preparations, as well as providing expert advice in the field of pharmaceutical and veterinary preparations; carrying out early evaluations in the field of new medicines as part of scientific research; development of pharmaceutical preparations, medicines and medicaments; evaluation of pharmaceutical products as part of scientific analysis and research; research and development in the pharmaceutical field; advice regarding the aforesaid research, development and analysis services as part of consultations about medicines; advice regarding scientific research and analysis relating to medicines; information with regard to scientific research in the field of biochemistry and biotechnology; scientific research, including in the medical sector
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [035]
Advertising, Business & Retail Services
Business consultancy services relating to manufacturing of medicinal and pharmaceutical preparations; business management advice relating to manufacturing business; advertising services; business management
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [040]
Treatment & Processing of Materials Services
Contract manufacturing services in the field of preparing medicines and pharmaceutical products; custom manufacturing of biopharmaceuticals; custom manufacturing of pharmaceutical products, namely, for treatment of cardiovascular disorders, for treating diabetes, for treating allergies, for treating hypertension, for treating asthma, for use in urology, for use in dermatology, for treating skin disorders, for peripheral nervous system, for use in chemotherapy, for the treatment of hyperlipidemia, for the central nervous system, for treatment of infectious diseases, for the treatment of viral diseases, for the treatment of autoimmune diseases, for the treatment of Musculo-skeletal disorders, for the treatment of gastro-intestinal diseases, for the treatment of immune system related diseases and disorders, kidney diseases or disorders, and diabetes; preparing medicines and pharmaceutical products being contract manufacturing services, also with the aid of biotechnology
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [005]
Pharmaceutical Products
Medicines and pharmaceutical preparations, namely, for treatment of cardiovascular disorders, for treating diabetes, for treating allergies, for treating hypertension, for treating asthma, for use in urology, for use in dermatology, for treating skin disorders, for peripheral nervous system, for use in chemotherapy, for the treatment of hyperlipidemia, for the central nervous system, for treatment of infectious diseases, for the treatment of viral diseases, for the treatment of autoimmune diseases, for the treatment of musculo-skeletal disorders, for the treatment of gastro-intestinal diseases, for the treatment of immune system related diseases and disorders, kidney diseases or disorders, and diabetes; dietary supplements for humans and animals
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [001]
Chemical Products
Chemical additives for use in manufacturing of pharmaceuticals; chemical additives for use in the manufacture of medicaments; chemicals used in industry and science; active chemical ingredients for use in the manufacture of pharmaceuticals for treating cardiovascular disorders, for treating diabetes, for treating allergies, for treating hypertension, for treating asthma, for use in urology, for use in dermatology, for treating skin disorders, for peripheral nervous system, for use in chemotherapy, for the treatment of hyperlipidemia, for the central nervous system, for treatment of infectious diseases, for the treatment of viral diseases, for the treatment of autoimmune diseases, for the treatment of musculo-skeletal disorders, for the treatment of gastro-intestinal diseases, for the treatment of immune system related diseases and disorders, kidney diseases or disorders, and diabete
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 79358195
Mark Type
No Service Mark
Attorney Docket Number
No 4964-107
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
Yes
66A Current
Yes
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 26th Nov 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 26th Nov 2024 | REGISTERED-PRINCIPAL REGISTER |
| 03rd Nov 2024 | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED |
| 23rd Jul 2024 | EXTENSION OF TIME TO OPPOSE RECEIVED |
| 25th Jun 2024 | PUBLISHED FOR OPPOSITION |
| 25th Jun 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 05th Jun 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 23rd May 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 14th May 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 13th May 2024 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |